Literature DB >> 783060

Long-term tolerance of healthy human subjects to high amounts of xylitol and fructose: general and biochemical findings.

K K Mäkinen.   

Abstract

Three groups of volunteers, totalling 125, lived for two years on strict diets so that comparisons might be made with regard to the sweeteners: fructose (F), sucrose (S), and xylitol (X). The sizes of the test groups were: S, 35; F, 38; X, 52. The average monthly amounts of the sugars consumed in a varied assortment of foods were: S, 2.2 kg; F, 2.1 kg; X, 1.5 kg. The highest daily doses of fructose and xylitol were 200 - 400 g (maximum 430 g xylitol). Serum samples were analyzed for several chemical parameters. The dietary regimens did not result in clinically significant changes between the sugar groups. The ability of X to produce osmotic diarrhoea and flatulence was found to depend on the individual physiological responses of each volunteer. In many cases no symptoms were found although high amounts (200 - 400 g) of X were consumed. All pregnancies and deliveries in the F and X groups were normal. Practically all the volunteers accepted the F and X foods (almost 100 varities) and adhered to the dietary regimen for two years. This was due in the main to the fact that most F and X products were comparable to those containing sucrose.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 783060

Source DB:  PubMed          Journal:  Int Z Vitam Ernahrungsforsch Beih        ISSN: 0373-0883


  4 in total

1.  Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis.

Authors:  Su-Ji Han; So-Yeon Jeong; Yun-Ju Nam; Kyu-Ho Yang; Hoi-Soon Lim; Jin Chung
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Diminished bone resorption in rats after oral xylitol administration: a dose-response study.

Authors:  P Mattila; M Svanberg; M Knuuttila
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

3.  Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis.

Authors:  Sachinkumar Singh; Douglas Hornick; Janel Fedler; Janice L Launspach; Mary E Teresi; Thomas R Santacroce; Joseph E Cavanaugh; Rebecca Horan; George Nelson; Timothy D Starner; Joseph Zabner; Lakshmi Durairaj
Journal:  J Cyst Fibros       Date:  2019-07-18       Impact factor: 5.482

4.  Safety assessment of inhaled xylitol in mice and healthy volunteers.

Authors:  Lakshmi Durairaj; Janice Launspach; Janet L Watt; Thomas R Businga; Joel N Kline; Peter S Thorne; Joseph Zabner
Journal:  Respir Res       Date:  2004-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.